Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Atherogenic Index of Plasma for the Prediction of Delirium in ICU Patients: A Retrospective Cohort Study Based on the MIMIC-IV Database.

Brain and behavior·2026
Same journal

Mendelian Randomization Analysis of Human Blood Metabolites and Sensorineural Hearing Loss.

Brain and behavior·2026
Same journal

Right‑DLPFC rTMS Transiently Modulates Risky Decision-Making and EEG Oscillatory Activity.

Brain and behavior·2026
Same journal

Sensory Tricks in Dystonia: A Systematic Review and Nested Quantitative Synthesis.

Brain and behavior·2026
Same journal

Suanzao Ren Decoction Alleviates Anxiety-Like Behavior and Cognitive Dysfunction in Chronic Unpredictable Stress Rats by Modulating Oxidative Stress and Autophagy.

Brain and behavior·2026
Same journal

Job Satisfaction, Self-Rated Work Performance, and Precuneus Gray Matter Volume: An Exploratory Neuroimaging Study.

Brain and behavior·2026

Related Experiment Video

Updated: Jul 10, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Multi-Trait Genetic Insights Into Schizophrenia Across Ancestries: Genome-Wide Association Meta-Analyses, Machine

Ping Yan1, Haili Wang1, Ye Shu2

  • 1Psychiatric Medical Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Brain and Behavior
|July 9, 2026
PubMed
Summary

This study reveals a shared genetic basis between schizophrenia (SC) and drug use, identifying 24 new SC risk loci. Findings suggest potential drug repurposing opportunities for SC treatment.

More Related Videos

A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior
06:59

A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior

Published on: May 21, 2020

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Related Experiment Videos

Last Updated: Jul 10, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior
06:59

A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior

Published on: May 21, 2020

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Area of Science:

  • Psychiatric Genetics
  • Genomics
  • Pharmacology

Background:

  • Schizophrenia (SC) is a complex psychiatric disorder with poorly understood genetic factors and links to drug use.
  • Genomic research has advanced, yet the genetic architecture of SC and its relationship with substance use remain unclear.

Purpose of the Study:

  • To investigate the genetic correlations between schizophrenia and various drug use traits.
  • To identify novel genetic loci and genes associated with schizophrenia risk.
  • To explore drug repurposing strategies for schizophrenia treatment.

Main Methods:

  • Genome-wide association studies (GWAS) data from large cohorts (European and East Asian ancestry) for SC and 23 drug use types.
  • Linkage disequilibrium score regression for genetic correlation analysis.
  • Meta-analysis of GWAS, molecular methodologies, and machine learning for SC diagnosis and drug repurposing.

Main Results:

  • Significant genetic correlations were found between SC and drug use across ancestries.
  • Identified 24 novel loci and highlighted new genes associated with SC risk.
  • Discovered ten drug classes, including cannabinoid receptor antagonists, with potential therapeutic relevance for SC.

Conclusions:

  • A common genetic foundation links schizophrenia susceptibility and drug use, offering new insights into SC's genetic architecture.
  • Novel identified loci and genes provide potential therapeutic targets for SC.
  • Drug repurposing presents a promising strategy for SC treatment, integrating genetic and pharmacological research.